Page 6 - Sarepta News Today

Citigroup assumed coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a report published on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $113.00 price target on the biotechnology company’s stock. A number of other brokerages have also recently weighed in on SRPT. Barclays dropped their price target on […]

TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET PPI; 2;00ET FOMC Rate Decision ECB, BOE, SNB policy meetings Thursday - PPI 0.0% MoM, Exp. 0.0%; PPI Core 0.0% MoM, Exp. 0.2% TODAY’S HIGHLIGHTS: ~90 Percent of Moscow's Pre-War Army Lost to Death or Injury, US Intelligence Estimate Says The United

Acadian Asset Management LLC reduced its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 49.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 498 shares of the biotechnology company’s stock after selling 494 shares during the period. Acadian Asset Management LLC’s holdings in Sarepta Therapeutics were worth $57,000 […]

TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Chicago Fed National Activity Index, Philadelphia Fed Non-Manufacturing Activity; 10:00ET Existing Home Sales; 1:00ET $15 billion 10-year TIPS auction; 2:00ET FOMC Meeting Minutes TODAY’S HIGHLIGHTS: ISRAEL-HAMAS DEAL ON 50 HOSTAGES CAN BE ANNOUNCED TODAY: CNN World stocks were subdued as

Van Riebeeck Hall was packed to the brim last Thursday evening (9 November) when Mayor Geordin Hill-Lewis and representatives of all City of Cape Town directorates were in town.

Earlier this year the Women’s Ministries department of Kuils River Seventh-day Adventist (SDA) Church embarked on a mission to teach young girls of 10 to 18 years life skills in the form of a 10-module course.

An education gap exists about 'the possibility that these drugs might not work,' says expert

Operator: Good afternoon and welcome to Cryoport Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target dropped by equities researchers at Needham & Company LLC from $185.00 to $82.00 in a report released on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Needham & Company LLC’s target price indicates a potential upside of […]

Typically, such local elections dont have a major impact outside their direct communities. But this one could decide control of the Virginia legislature and Republican Gov. Glenn Youngkins... -November 01, 2023 at 06:13 am EDT - MarketScreener